Menu
Currency
GWAS Study

Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study.

Lee E, Takita C, Wright JL et al.

31196165 PubMed ID
GWAS Study Type
1112 Participants
42 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LE
Lee E
TC
Takita C
WJ
Wright JL
SS
Slifer SH
ME
Martin ER
UJ
Urbanic JJ
LC
Langefeld CD
LG
Lesser GJ
SE
Shaw EG
HJ
Hu JJ
Chapter II

Abstract

Summary of the research findings

Adjuvant radiotherapy (RT) can increase the risk of developing pain; however, the molecular mechanisms of RT-related pain remain unclear. The current study aimed to identify susceptibility loci and enriched pathways for clinically relevant acute post-RT pain, defined as having moderate to severe pain (pain score ≥ 4) at the completion of RT.

136 Hispanic cases, 75 European ancestry cases, 102 African ancestry cases, 45 cases, 265 Hispanic controls, 282 European ancestry controls, 194 African ancestry controls, 45 controls

Chapter III

Study Statistics

Key metrics and study information

1112
Total Participants
GWAS
Study Type
No
Replicated
European, Other, Hispanic or Latin American, African unspecified, African American or Afro-Caribbean
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.